Literature DB >> 24259030

Histological step sectioning of pelvic lymph nodes increases the number of identified lymph node metastases.

Birte Engvad1, Mads H Poulsen, Pia W Staun, Steen Walter, Niels Marcussen.   

Abstract

Pathological examinations of lymph nodes (LN) in prostate cancer patients are handled differently at various institutions. The objective of this study is to provide means to improve the guidelines by examining the impact of step sectioning on LN status in patients with intermediate and high-risk prostate cancer. Two hundred ten patients who awaited curative indented therapy were included. We first performed a standard pathological examination of the LN, followed by an extended pathological examination of the patients who were LN negative in the standard examination. The extended pathological examination included a 100-μm-deep haematoxylin and eosin (HE) section followed by a slide stained with cytokeratin AE1/AE3 and then by four HE sections at 0.5-mm intervals.The standard pathological examination detected 41 patients with LN metastasis. The remaining 169 patients had 1,185 HE sections made at the standard examination, whereas the extended examination gave additional 7,110 slides and detected 5 additional patients with LN metastasis. In all, 1,158 LN were removed. The additional LN metastases were smaller than the LN metastases found at the standard examination, mean 1.2 mm vs. 7.8 mm.Our results indicate that an extended pathological examination of LN will improve the staging of intermediate- and high-risk prostate cancer patients; however, we acknowledge that it is both costly and time consuming. We do not recommend the use of cytokeratin staining in routine staining because the immunohistochemistry did not reveal new or further information. A detailed guideline on how to handle the LN specimens at the pathological department is needed.

Entities:  

Mesh:

Year:  2013        PMID: 24259030     DOI: 10.1007/s00428-013-1510-5

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  29 in total

1.  Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?

Authors:  Pia Bader; Fiona C Burkhard; Regula Markwalder; Urs E Studer
Journal:  J Urol       Date:  2003-03       Impact factor: 7.450

Review 2.  International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 4: seminal vesicles and lymph nodes.

Authors:  Daniel M Berney; Thomas M Wheeler; David J Grignon; Jonathan I Epstein; David F Griffiths; Peter A Humphrey; Theo van der Kwast; Rodolfo Montironi; Brett Delahunt; Lars Egevad; John R Srigley
Journal:  Mod Pathol       Date:  2010-09-03       Impact factor: 7.842

3.  Pelvic lymph node dissection in prostate cancer: the mystery is taking shape.

Authors:  Alberto Briganti; Nazareno Suardi; Andrea Gallina; Firas Abdollah; Francesco Montorsi
Journal:  Eur Urol       Date:  2012-08-25       Impact factor: 20.096

4.  EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease.

Authors:  Axel Heidenreich; Joaquim Bellmunt; Michel Bolla; Steven Joniau; Malcolm Mason; Vsevolod Matveev; Nicolas Mottet; Hans-Peter Schmid; Theo van der Kwast; Thomas Wiegel; Filliberto Zattoni
Journal:  Eur Urol       Date:  2010-10-28       Impact factor: 20.096

5.  Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients.

Authors:  Dorothea Weckermann; Robert Dorn; M Trefz; Theodor Wagner; Friedhelm Wawroschek; Rolf Harzmann
Journal:  J Urol       Date:  2007-03       Impact factor: 7.450

6.  Cancer volume of lymph node metastasis predicts progression in prostate cancer.

Authors:  L Cheng; E J Bergstralh; J C Cheville; J Slezak; F A Corica; H Zincke; M L Blute; D G Bostwick
Journal:  Am J Surg Pathol       Date:  1998-12       Impact factor: 6.394

7.  Survival in surgically treated, nodal positive prostate cancer patients is predicted by histopathological characteristics of the primary tumor and its lymph node metastases.

Authors:  Achim Fleischmann; Sylviane Schobinger; Martin Schumacher; George N Thalmann; Urs E Studer
Journal:  Prostate       Date:  2009-03-01       Impact factor: 4.104

8.  Micrometastases or isolated tumor cells and the outcome of breast cancer.

Authors:  Maaike de Boer; Carolien H M van Deurzen; Jos A A M van Dijck; George F Borm; Paul J van Diest; Eddy M M Adang; Johan W R Nortier; Emiel J T Rutgers; Caroline Seynaeve; Marian B E Menke-Pluymers; Peter Bult; Vivianne C G Tjan-Heijnen
Journal:  N Engl J Med       Date:  2009-08-13       Impact factor: 91.245

9.  Histopathological characteristics of lymph node metastases predict cancer-specific survival in node-positive prostate cancer.

Authors:  Joost L Boormans; Mark F Wildhagen; Chris H Bangma; Paul C Verhagen; Geert J van Leenders
Journal:  BJU Int       Date:  2008-08-14       Impact factor: 5.588

10.  Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes.

Authors:  Shahrokh F Shariat; Martine P Roudier; George E Wilcox; Michael W Kattan; Peter T Scardino; Robert L Vessella; Sibel Erdamar; Cuong Nguyen; Thomas M Wheeler; Kevin M Slawin
Journal:  Cancer Res       Date:  2003-08-01       Impact factor: 12.701

View more
  6 in total

Review 1.  Update on histopathological evaluation of lymphadenectomy specimens from prostate cancer patients.

Authors:  Alessandro Conti; Matteo Santoni; Luciano Burattini; Marina Scarpelli; Roberta Mazzucchelli; Andrea B Galosi; Liang Cheng; Antonio Lopez-Beltran; Alberto Briganti; Francesco Montorsi; Rodolfo Montironi
Journal:  World J Urol       Date:  2015-12-22       Impact factor: 4.226

2.  Added value of cost-utility analysis in simple diagnostic studies of accuracy: (18)F-fluoromethylcholine PET/CT in prostate cancer staging.

Authors:  Oke Gerke; Mads H Poulsen; Poul Flemming Høilund-Carlsen
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-01-15

Review 3.  A practical guide to bladder cancer pathology.

Authors:  Eva Compérat; Justine Varinot; Julien Moroch; Caroline Eymerit-Morin; Fadi Brimo
Journal:  Nat Rev Urol       Date:  2018-01-31       Impact factor: 14.432

Review 4.  Updated pathology reporting standards for bladder cancer: biopsies, transurethral resections and radical cystectomies.

Authors:  Eva Compérat; André Oszwald; Gabriel Wasinger; Donna E Hansel; Rodolfo Montironi; Theodorus van der Kwast; Johannes A Witjes; Mahul B Amin
Journal:  World J Urol       Date:  2021-09-23       Impact factor: 3.661

5.  How Image-Guided Pathology Can Improve the Detection of Lymph Node Metastases in Prostate Cancer.

Authors:  Melline G M Schilham; Heidi Küsters-Vandevelde; Diederik M Somford; M Rijpkema; Martin Gotthardt
Journal:  Clin Nucl Med       Date:  2022-04-19       Impact factor: 10.782

6.  Identification of molecular biomarkers for the diagnosis of gastric cancer and lymph-node metastasis.

Authors:  Sharvesh Raj Seeruttun; Wing Yan Cheung; Wei Wang; Cheng Fang; Zhi-Min Liu; Jin-Qing Li; Ting Wu; Jun Wang; Chun Liang; Zhi-Wei Zhou
Journal:  Gastroenterol Rep (Oxf)       Date:  2018-08-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.